Navigating the Costs of Fertility Treatments and Weight Loss Medications

This chapter examines the financial aspects of IVF treatments and GLP-1 medications, emphasizing the prohibitive costs of IVF and the shift towards cash-pay models for GLP-1 drugs. It also showcases Cigna's novel strategies to improve accessibility and affordability in the weight loss medication sector through lifestyle programs and employer involvement.